Interaction of Estrogen and Tumor Necrosis Factor α in Endothelial Cell Migration and Early Stage of Angiogenesis

REFERENCES

• Al Ghouleh I., Magder S. Nicotinamide adenine dinucleotide phosphate (reduced form) oxidase is important for LPS-induced endothelial cell activation. Shock 2008; 29: 553–559
   PubMed Web of Science ®Google Scholar
• Angerer P., Stork S., Kothny W., Schmitt P., von Schacky C. Effect of oral postmenopausal hormone replacement on progression of atherosclerosis: A randomized, controlled trial. Arteriosclerosis, Thrombosis, and Vascular Biology 2001; 21: 262–268
   PubMed Web of Science ®Google Scholar
• Arenas I. A., Armstrong S. J., Xu Y., Davidge S. T. Chronic tumor necrosis factor-alpha inhibition enhances NO modulation of vascular function in estrogen-deficient rats. Hypertension 2005; 46: 76–81
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation 1997; 95: 252–264
   PubMed Web of Science ®Google Scholar
• Berthois Y., Katzenellenbogen J. A., Katzenellenbogen B. S. Phenol red in tissue culture media is a weak estrogen Implications concerning the study of estrogen-responsive cells in culture. Proceedings of the National Academy of Sciences of the United States of America 1986; 83: 2496–2500
   PubMed Web of Science ®Google Scholar
• Bokoch G. M. Biology of the p21-activated kinases. Annual Review of Biochemistry 2003; 72: 743–781
   PubMed Web of Science ®Google Scholar
• Brouchet L., Krust A., Dupont S., Chambon P., Bayard F., Arnal J. F. Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta. Circulation 2001; 103: 423–428
   PubMed Web of Science ®Google Scholar
• Caulin-Glaser T., Watson C. A., Pardi R., Bender J. R. Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. The Journal of Clinical Investigation 1996; 98: 36–42
   PubMed Web of Science ®Google Scholar
• Dantas A. P., Sandberg K. Estrogen regulation of tumor necrosis factor-alpha: A missing link between menopause and cardiovascular risk in women?. Hypertension 2005; 46: 21–22
   PubMed Web of Science ®Google Scholar
• Farhat M. Y., Lavigne M. C., Ramwell P. W. The vascular protective effects of estrogen. The FASEB Journal 1996; 10: 615–624
   PubMed Web of Science ®Google Scholar
• Fletcher S. W., Colditz G. A. Failure of estrogen plus progestin therapy for prevention. Journal of the American Medical Association 2002; 288: 366–368
   PubMed Web of Science ®Google Scholar
• Florian M., Lu Y., Angle M., Magder S. Estrogen induced changes in Akt-dependent activation of endothelial nitric oxide synthase and vasodilation. Steroids 2004; 69: 637–645
   PubMed Web of Science ®Google Scholar
• Florian M., Magder S. Estrogen decreases TNF-alpha and oxidized LDL induced apoptosis in endothelial cells. Steroids 2008; 73: 47–58
   PubMed Web of Science ®Google Scholar
• Frater-Schroder M., Risau W., Hallmann R., Gautschi P., Bohlen P. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proceedings of the National Academy of Sciences of the United States of America 1987; 84: 5277–5281
   PubMed Web of Science ®Google Scholar
• Gargett C. E., Zaitseva M., Bucak K., Chu S., Fuller P. J., Rogers P. A. 17Beta-estradiol up-regulates vascular endothelial growth factor receptor-2 expression in human myometrial microvascular endothelial cells: Role of estrogen receptor-alpha and -beta. The Journal of Clinical Endocrinology and Metabolism 2002; 87: 4341–4349
   PubMed Web of Science ®Google Scholar
• Gerhard M., Ganz P. How do we explain the clinical benefits of estrogen? From bedside to bench. Circulation 1995; 92: 5–8
   PubMed Web of Science ®Google Scholar
• Gertzberg N., Neumann P., Rizzo V., Johnson A. NAD(P)H oxidase mediates the endothelial barrier dysfunction induced by TNF-alpha. American Journal of Physiology, Lung, Cellular and Molecular Physiology 2004; 286: L37–L48
   PubMed Web of Science ®Google Scholar
• Giraudo E., Primo L., Audero E., Gerber H. P., Koolwijk P., Soker S., Klagsbrun M., Ferrara N., Bussolino F. Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. The Journal of Biological Chemistry 1998; 273: 22128–22135
   PubMed Web of Science ®Google Scholar
• Grady D., Rubin S. M., Petitti D. B., Fox C. S., Black D., Ettinger B., Ernster V. L., Cummings S. R. Hormone therapy to prevent disease and prolong life in postmenopausal women. Annals of internal medicine 1992; 117: 1016–1037
   PubMed Web of Science ®Google Scholar
• Grainger D. J., Metcalfe J. C. Tamoxifen: Teaching an old drug new tricks?. Nature Medicine 1996; 2: 381–385
   PubMed Web of Science ®Google Scholar
• Grodstein F., Stampfer M. J., Colditz G. A., Willett W. C., Manson J. E., Joffe M., Rosner B., Fuchs C., Hankinson S. E., Hunter D. J., Hennekens C. H., Speizer F. E. Postmenopausal hormone therapy and mortality. The New England journal of Medicine 1997; 336: 1769–1775
   PubMed Web of Science ®Google Scholar
• Grodstein F., Stampfer M. J., Manson J. E., Colditz G. A., Willett W. C., Rosner B., Speizer F. E., Hennekens C. H. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. The New England Journal of Medicine 1996; 335: 453–461
   PubMed Web of Science ®Google Scholar
• Gruber C. J., Tschugguel W., Schneeberger C., Huber J. C. Production and actions of estrogens. The New England Journal of Medicine 2002; 346: 340–352
   PubMed Web of Science ®Google Scholar
• Hodgin J. B., Krege J. H., Reddick R. L., Korach K. S., Smithies O., Maeda N. Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in ApoE-/- mice. The Journal of Clinical Investigation 2001; 107: 333–340
   PubMed Web of Science ®Google Scholar
• Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Journal of the American Medical Association 1998; 280: 605–613
   PubMed Web of Science ®Google Scholar
• Karas R. H. Animal models of the cardiovascular effects of exogenous hormones. The American Journal of Cardiology 2002; 90: 22F–25F
   PubMed Web of Science ®Google Scholar
• Karas R. H., Hodgin J. B., Kwoun M., Krege J. H., Aronovitz M. J., Mackey W., Gustafsson J. A., Korach K. S., Smithies O., Mendelsohn M. E. Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice. Proceedings of the National Academy of Sciences of the United States of America 1999; 96: 15133–15136
   PubMed Web of Science ®Google Scholar
• Katzenellenbogen J. A., Johnson H. J., Jr., Myers H. N. Photoaffinity labels for estrogen binding proteins of rat uterus. Biochemistry 1973; 12: 4085–4092
   PubMed Web of Science ®Google Scholar
• Klagsbrun M., D'Amore P. A. Regulators of angiogenesis. Annual Review of Physiology 1991; 53: 217–239
   PubMed Web of Science ®Google Scholar
• Koch A. E., Polverini P. J., Kunkel S. L., Harlow L. A., DiPietro L. A., Elner V. M., Elner S. G., Strieter R. M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798–1801
   PubMed Web of Science ®Google Scholar
• Krasinski K., Spyridopoulos I., Asahara T., van der Z. R., Isner J. M., Losordo D. W. Estradiol accelerates functional endothelial recovery after arterial injury. Circulation 1997; 95: 1768–1772
   PubMed Web of Science ®Google Scholar
• Lau Y. T., Ma W. C. Nitric oxide inhibits migration of cultured endothelial cells. Biochemical and Biophysical Research Communications 1996; 221: 670–674
   PubMed Web of Science ®Google Scholar
• Leibovich S. J., Polverini P. J., Shepard H. M., Wiseman D. M., Shively V., Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 1987; 329: 630–632
   PubMed Web of Science ®Google Scholar
• Levin E. R. Estrogen receptor-beta and the cardiovascular system. Trends in Endocrinology and Metabolism 2002; 13: 184–185
   PubMed Web of Science ®Google Scholar
• Losordo D. W., Isner J. M. Estrogen and angiogenesis, A review. Arteriosclerosis, Thrombosis, and Vascular Biology 2001; 21: 6–12
   PubMed Web of Science ®Google Scholar
• Mazumdar A., Kumar R. Estrogen regulation of Pak1 and FKHR pathways in breast cancer cells. FEBS Letters 2003; 535: 6–10
   PubMed Web of Science ®Google Scholar
• Mendelsohn M. E. Nongenomic, ER-mediated activation of endothelial nitric oxide synthase: How does it work? What does it mean?. Circulation Research 2000; 87: 956–960
   PubMed Web of Science ®Google Scholar
• Mendelsohn M. E. Protective effects of estrogen on the cardiovascular system. The American Journal of Cardiology 2002; 89: 12E–17E
   Web of Science ®Google Scholar
• Mendelsohn M. E., Karas R. H. Estrogen and the blood vessel wall. Current Opinion in Cardiology 1994; 9: 619–626
   PubMed Web of Science ®Google Scholar
• Mendelsohn M. E., Karas R. H. The protective effects of estrogen on the cardiovascular system. The New England Journal of Medicine 1999; 340: 1801–1811
   PubMed Web of Science ®Google Scholar
• Mikkola T. S., Clarkson T. B. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovascular Research 2002; 53: 605–619
   PubMed Web of Science ®Google Scholar
• Morales D. E., McGowan K. A., Grant D. S., Maheshwari S., Bhartiya D., Cid M. C., Kleinman H. K., Schnaper H. W. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 1995; 91: 755–763
   PubMed Web of Science ®Google Scholar
• Mosca L., Manson J. E., Sutherland S. E., Langer R. D., Manolio T., Barrett-Connor E. Cardiovascular disease in women: A statement for healthcare professionals from the American Heart Association. Writing Group. Circulation 1997; 96: 2468–2482
   PubMed Web of Science ®Google Scholar
• Murohara T., Asahara T., Silver M., Bauters C., Masuda H., Kalka C., Kearney M., Chen D., Symes J. F., Fishman M. C., Huang P. L., Isner J. M. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. The Journal of Clinical Investigation 1998; 101: 2567–2578
   PubMed Web of Science ®Google Scholar
• Papapetropoulos A., Garcia-Cardena G., Madri J. A., Sessa W. C. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. The Journal of Clinical Investigation 1997; 3131–3139
   PubMed Web of Science ®Google Scholar
• Pare G., Krust A., Karas R. H., Dupont S., Aronovitz M., Chambon P., Mendelsohn M. E. Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circulation Research 2002; 90: 1087–1092
   PubMed Web of Science ®Google Scholar
• Peters K. G., Kontos C. D., Lin P. C., Wong A. L., Rao P., Huang L., Dewhirst M. W., Sankar S. Functional significance of Tie2 signaling in the adult vasculature. Recent Progress in Hormone Research 2004; 59: 51–71
   PubMedGoogle Scholar
• Petitti D. B. Hormone replacement therapy and heart disease prevention: Experimentation trumps observation. Journal of the American Medical Association 1998; 280: 650–652
   Web of Science ®Google Scholar
• Pipili-Synetos E., Sakkoula E., Haralabopoulos G., Andriopoulou P., Peristeris P., Maragoudakis M. E. Evidence that nitric oxide is an endogenous antiangiogenic mediator. British Journal of Pharmacology 1994; 111: 894–902
   PubMed Web of Science ®Google Scholar
• Razandi M., Pedram A., Levin E. R. Estrogen signals to the preservation of endothelial cell form and function. The Journal of Biological Chemistry 2000; 275: 38540–38546
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801–809
   PubMed Web of Science ®Google Scholar
• Rossouw J. E. Hormones, genetic factors, and gender differences in cardiovascular disease. Cardiovascular Research 2002; 53: 550–557
   PubMed Web of Science ®Google Scholar
• Rossouw J. E., Anderson G. L., Prentice R. L., LaCroix A. Z., Kooperberg C., Stefanick M. L., Jackson R. D., Beresford S. A., Howard B. V., Johnson K. C., Kotchen J. M., Ockene J., Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 2002; 321–333
   Web of Science ®Google Scholar
• Ruohola J. K., Valve E. M., Karkkainen M. J., Joukov V., Alitalo K., Harkonen P. L. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Molecular and Cellular Endocrinology 1999; 149: 29–40
   PubMed Web of Science ®Google Scholar
• Schulman S. P., Thiemann D. R., Ouyang P., Chandra N. C., Schulman D. S., Reis S. E., Terrin M., Forman S., de Albuquerque C. P., Bahr R. D., Townsend S. N., Cosgriff R., Gerstenblith G. Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina. Journal of the American College of Cardiology 2002; 39: 231–237
   PubMed Web of Science ®Google Scholar
• Sotelo M. M., Johnson S. R. The effects of hormone replacement therapy on coronary heart disease. Endocrinology and Metabolism Clinics of North America 1997; 26: 313–328
   PubMed Web of Science ®Google Scholar
• Spyridopoulos I., Sullivan A. B., Kearney M., Isner J. M., Losordo D. W. Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor. Circulation 1997; 95: 1505–1514
   PubMed Web of Science ®Google Scholar
• Viscoli C. M., Brass L. M., Kernan W. N., Sarrel P. M., Suissa S., Horwitz R. I. A clinical trial of estrogen-replacement therapy after ischemic stroke. The New England Journal of Medicine 2001; 345: 1243–1249
   PubMed Web of Science ®Google Scholar
• Williams J. K., Honore E. K., Washburn S. A., Clarkson T. B. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. Journal of the American College of Cardiology 1994; 24: 1757–1761
   PubMed Web of Science ®Google Scholar
• Xu Y., Arenas I. A., Armstrong S. J., Plahta W. C., Xu H., Davidge S. T. Estrogen improves cardiac recovery after ischemia/reperfusion by decreasing tumor necrosis factor-alpha. Cardiovascular Research 2006; 69: 836–844
   PubMed Web of Science ®Google Scholar
• Ye F., Florian M., Magder S., Hussain S. Regulation of angiopoietin and Tie-2 receptor expression in non-reproductive tissues by estrogen. Steroids 2002; 67: 305–310
   PubMed Web of Science ®Google Scholar